These mechanisms could be important in breast cancer where STAT3 is often constitutively active, and it has also been shown that higher levels of IL-6 in the blood of metastatic breast cancer patients correlates with poor prognosis [57,58]. This evidence concerns the gene IL6 and breast carcinoma.